Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT) [Phase 1]

View source ↗

Summary

Phase 1 trial assessing bioequivalence between levocetirizine oral disintegrating tablet and immediate-release tablet for rhinitis; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levocetirizine immediate-release tablet (levocetirizine)
  • levocetirizine oral disintegrating tablet (levocetirizine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 1 | Status: COMPLETED | Results posted: 2019-09-12